Description
Global Microarray Analysis Market
By Product& Services (Consumables, Software and Services, Others), By Type (DNA Microarrays, Protein Microarrays), By Application (Drug discovery, Disease Diagnostic, Research Applications), By End User (Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027
Market Review
The microarray analysis market is anticipated to reach USD 6,607.64 million by 2027 to witness a healthy CAGR of 7.76%. Microarray is an incredible methodology used to examine quality articulation for different trial purposes. Various microarray stages are accessible for testing. The advancement of microarrays had worked on the aftereffects of hereditary testing.
The worldwide microarrays investigation market is significantly determined by the high pervasiveness of malignancy and the rising requirement for research in drug enterprises. However, the Presence of substitutes and lack of skilled professionals are expected to restrain the global market growth during the review period.
The expanding commonness of various ongoing sicknesses, utilization of this procedure to analyze irresistible illnesses, improvement in the field of hereditary qualities, and expanding medical care consumption have given a push to the market.
The growth of the global market is attributed to the increasing application area of microarrays, the increasing prevalence of cancer, and Funding for genomic and proteomic research. Nevertheless, the significant expense of tests and the requirement for innovative instruments might control the development of the microarray investigation market.
Market Segmentation
The global Microarrays market has been classified into Product & Services, type, and application.
In terms of products and services, the global market has been divided into Consumables, Software and Services, and Instruments.
By Type segment, the global market is categorized into DNA Microarrays, Protein Microarrays, and others.
Based on Application the market has been classified into Drug Discovery, Disease Diagnostics, Research Applications, and Others
Global Microarray Analysis Market, based on End User has been classified into Research Academic Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Others
Regional Analysis
The global microarray analysis market, in terms of region, has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
In 2019, the Americas represented the biggest portion of the overall industry of 40.98% and were assessed to overwhelm the worldwide microarray investigation market all through the estimated time frame.
This biggest portion of the overall industry can be credited to the expanding reception of new advances and the presence of a key part in the district. The Americas is additionally ordered into North America and Latin America.
Europe holds a sound offer in the worldwide microarray examination market and is the second-biggest market after the Americas, attributable to the exceptionally created medical care industry, conspicuous exploration and improvement framework, and availability of items.
The microarray investigation market in Asia-Pacific is divided into China, Japan, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific. This territorial market is expected to be the second quickest developing market.
Major players
The major Companies Covered in Microarray Analysis Market Report are Agilent Technologies (US), Bio-Rad Laboratories (US), Illumina (US), Thermo Fisher Scientific (US), Microarrays, Inc. (US), PerkinElmer, Inc. (US), Merck KGaA (Germany), GE Healthcare (US), Danaher Corporation (US), and Arrayit Corporation (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 GROWING APPLICATION AREAS OF MICROARRAYS
4.2.2 INCREASING INCIDENCE OF CANCER
4.2.3 FUNDING FOR GENOMIC AND PROTEOMIC RESEARCH
4.3 RESTRAINTS
4.3.1 PRESENCE OF SUBSTITUTES AND LACK OF SKILLED PROFESSIONALS
4.4 OPPORTUNITIES
4.4.1 NEW PRODUCT LAUNCH IN DEVELOPING MARKETS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE MICROARRAY ANALYSIS MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON SUPPLY CHAIN
5.3.3 IMPACT ON DEVELOPMENT OF NEW MICROARRAY PRODUCTS FOR MAPPING COVID-19
6 GLOBAL MICROARRAY ANALYSIS MARKET, BY PRODUCT AND SERVICES
6.1 OVERVIEW
6.2 CONSUMABLES
6.3 SOFTWARE AND SERVICES
6.4 INSTRUMENTS
7 GLOBAL MICROARRAY ANALYSIS MARKET, BY TYPE
7.1 OVERVIEW
7.2 DNA MICROARRAYS
7.3 PROTEIN MICROARRAYS
7.4 OTHERS
8 GLOBAL MICROARRAY ANALYSIS MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 DRUG DISCOVERY
8.3 DISEASE DIAGNOSTICS
8.4 RESEARCH APPLICATIONS
8.5 OTHERS
9 GLOBAL MICROARRAY ANALYSIS MARKET, BY END USERS
9.1 OVERVIEW
9.2 RESEARCH & ACADEMIC INSTITUTES
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.4 DIAGNOSTIC LABORATORIES
9.5 OTHERS
10 GLOBAL MICROARRAY ANALYSIS MARKET, BY REGION
10.1 OVERVIEW
10.2 AMERICAS
10.2.1 NORTH AMERICA
10.2.1.1 U.S.
10.2.1.2 CANADA
10.2.2 LATIN AMERICA
10.3 EUROPE
10.3.1 WESTERN EUROPE
10.3.1.1 GERMANY
10.3.1.2 FRANCE
10.3.1.3 UK
10.3.1.4 ITALY
10.3.1.5 SPAIN
10.3.1.6 REST OF WESTERN EUROPE
10.3.2 EASTERN EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 SOUTH KOREA
10.4.5 AUSTRALIA
10.4.6 REST OF ASIA-PACIFIC
10.5 MIDDLE EAST & AFRICA
10.5.1 MIDDLE EAST
10.5.2 AFRICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE BENCHMARKING
11.4 MAJOR GROWTH STRATEGY IN THE GLOBAL MICROARRAY ANALYSIS MARKET
11.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL MICROARRAY MARKET
11.6 KEY DEVELOPMENT ANALYSIS
11.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.7.1 PRODUCT LAUNCHES/PRODUCT APPROVALS
11.7.2 PARTNERSHIPS/AGREEMENTS
11.7.3 ACQUISITIONS
11.7.4 EXPANSIONS
12 COMPANY PROFILES
12.1 THERMO FISHER SCIENTIFIC INC.
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS/SERVICES OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 AGILENT TECHNOLOGIES
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS/SERVICES OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 ILLUMINA
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 PERKINELMER, INC
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS/SERVICES OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 MERCK KGAA
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS/SERVICES OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 GE HEALTHCARE
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS/SERVICES OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 DANAHER CORPORATION
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS/SERVICES OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 ARRAYIT CORPORATION
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS/SERVICES OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 BIO-RAD LABORATORIES
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS/SERVICES OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 MICROARRAYS INC.
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS/SERVICES OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
